Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
2(50.0%)
Phase 2
2(50.0%)
4Total
Phase 1(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT02239562Phase 1Completed

sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS

Role: collaborator

NCT02761772Completed

Early Pregnancy Cohort and Preimplantation Factor

Role: collaborator

NCT03593460Phase 2Withdrawn

Phase II AutoImmune Hepatitis

Role: collaborator

NCT03593421Phase 2Withdrawn

Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies

Role: collaborator

NCT02129998Completed

The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology

Role: collaborator

NCT00517907Phase 1Unknown

Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)

Role: collaborator

NCT01805102Unknown

Correlation Between PIF Maternal Serum Levels and Pregnancy Outcome

Role: lead

NCT01803893Unknown

Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome

Role: lead

All 8 trials loaded